MITCHELL, IAN S.,BLAKE, JAMES F.,XU, RUI,KALLAN, NICHOLAS C.,XIAO, DENGMING,SPENCER, KEITH LEE,BENCSIK, JOSEF R.,LIANG, JUN,SAFINA, BRIAN,LI, JUN,CHABOT, CHRISTINE,BANKA, ANNA.L.,WALLACE, ELI. M.,SCHL,MITCHELL IAN S.,BLAKE JAMES F.,XU RUI,KALLAN NICHOLAS C.,XIAO DENGMING,SPENCER KEITH LEE,BENCSIK JOSEF R.,BENCS
申请号：
PL07799329
公开号：
PL2049500T3
申请日:
2007.07.05
申请国别(地区):
PL
年份:
2012
代理人:
摘要：
The present invention provides compounds of Formula I, including tautomers, resolved enantiomers, diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof. Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
